159 related articles for article (PubMed ID: 6145360)
1. The positive effect of alprazolam in the treatment of three patients with borderline personality disorder.
Faltus FJ
Am J Psychiatry; 1984 Jun; 141(6):802-3. PubMed ID: 6145360
[TBL] [Abstract][Full Text] [Related]
2. Alprazolam-induced dyscontrol in borderline personality disorder.
Gardner DL; Cowdry RW
Am J Psychiatry; 1985 Jan; 142(1):98-100. PubMed ID: 2857071
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy of the borderline patient: a critical review and clinical guidelines.
Kutcher SP; Blackwood DH
Can J Psychiatry; 1989 May; 34(4):347-53. PubMed ID: 2567621
[TBL] [Abstract][Full Text] [Related]
4. Benzodiazepines in the treatment of depressive, borderline personality, and schizophrenic disorders.
Schatzberg AF; Cole JO
Br J Clin Pharmacol; 1981; 11 Suppl 1(Suppl 1):17S-22S. PubMed ID: 6133529
[No Abstract] [Full Text] [Related]
5. [Relation between the effect of tranquilizers and various features of personality structure among patients with borderline states].
Aleksandrovskiĭ IuA; Khrulenko-Varnitskiĭ IO; Uvarova LG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(9):1367-76. PubMed ID: 6506985
[TBL] [Abstract][Full Text] [Related]
6. [The value of psychopharmacotherapy in the treatment of borderline personality disorder].
Leitner P; Serfling R
Psychiatr Prax; 1993 Nov; 20(6):207-10. PubMed ID: 7906044
[TBL] [Abstract][Full Text] [Related]
7. Psychopharmacologic approaches to the borderline patient.
Zisook S; Ricketts JE
Hillside J Clin Psychiatry; 1988; 10(1):55-70. PubMed ID: 2900799
[TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy for patients with borderline personality disorder.
Goldberg SC; Schulz SC
Arch Gen Psychiatry; 1988 Feb; 45(2):195-6. PubMed ID: 2892479
[No Abstract] [Full Text] [Related]
9. Psychopharmacology of borderline personality disorder: a review.
Cowdry RW
J Clin Psychiatry; 1987 Aug; 48 Suppl():15-25. PubMed ID: 2886493
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy for patients with borderline personality disorder.
Gunderson JG
Arch Gen Psychiatry; 1986 Jul; 43(7):698-700. PubMed ID: 2872871
[No Abstract] [Full Text] [Related]
11. Neuroleptic treatment in the borderline patient: advantages and techniques.
Soloff PH
J Clin Psychiatry; 1987 Aug; 48 Suppl():26-31. PubMed ID: 2886494
[TBL] [Abstract][Full Text] [Related]
12. [Clinico-pharmacological characteristics of combined administration of tranquilizing agents and other psychotropic drugs].
Aleksandrovskiĭ IuA; Neznamov GG; Tarnavskiĭ IuB; Valueva LN; Sigunova EA
Farmakol Toksikol; 1982; 45(3):36-41. PubMed ID: 7095127
[No Abstract] [Full Text] [Related]
13. [Personality disorder].
André C
Rev Prat; 2008 Mar; 58(5):551-6; quiz 575. PubMed ID: 18524115
[No Abstract] [Full Text] [Related]
14. Inhibited female orgasm as a side effect of alprazolam.
Sangal R
Am J Psychiatry; 1985 Oct; 142(10):1223-4. PubMed ID: 2863987
[No Abstract] [Full Text] [Related]
15. Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine.
Cowdry RW; Gardner DL
Arch Gen Psychiatry; 1988 Feb; 45(2):111-9. PubMed ID: 3276280
[TBL] [Abstract][Full Text] [Related]
16. [Borderline personality disorder].
Galinowski A
Encephale; 2005 Oct; 31 Pt 2():S73-5. PubMed ID: 16673717
[No Abstract] [Full Text] [Related]
17. Pharmacological treatments for personality disorders.
Paris J
Int Rev Psychiatry; 2011 Jun; 23(3):303-9. PubMed ID: 21923229
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacological treatment for patients with borderline personality disorder: practice and study results].
Schwerthöffer D; Bäuml J; Rentrop M
Fortschr Neurol Psychiatr; 2013 Aug; 81(8):437-43. PubMed ID: 23939557
[TBL] [Abstract][Full Text] [Related]
19. Differential diagnosis of coagulation abnormalities in borderline personality disorder.
Malevani J; Mobascher J; Cordes J; Mobascher A
World J Biol Psychiatry; 2008; 9(1):78-80. PubMed ID: 17853273
[TBL] [Abstract][Full Text] [Related]
20. Combination alprazolam-neuroleptic treatment of the positive and negative symptoms of schizophrenia.
Wolkowitz OM; Pickar D; Doran AR; Breier A; Tarell J; Paul SM
Am J Psychiatry; 1986 Jan; 143(1):85-7. PubMed ID: 2867690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
